Valuing benefits represents one of the greatest challenges facing health economists. Mandy argues that health economists have been too narrow, and clinical, in their valuation of benefits. She argues the case for broadening the valuation space to be more person-centered, and looks at how health economics can contribute to this.
Mandy is the Director of the Health Economics Research Unit. She joined HERU in 1987 after graduating from the University of Leicester with a BA (Hons) in Economics and the University of York with an MSc in Health Economics. In 1995 she graduated from the University of Aberdeen with a PhD in Economics concerned with the application of contingent valuation and discrete choice experiments in health economics. In 1997 Mandy was awarded a five-year MRC Senior Fellowship to develop and apply discrete choice experiments in health care; in 2002 she was awarded a Personal Chair in Health Economics by the University of Aberdeen; and in 2006 she was elected as a Fellow of the Royal Society of Edinburgh. She took up the Directorship of HERU in April 2013.
Mandy has worked with academics, government and the pharmaceutical industry and has published widely in the field of health economics generally, and monetary valuation more specifically. She has extensive teaching experience, and currently contributes to HERU’s annual expert Discrete Choice Experiment Workshop. In 2012 Mandy was ranked amongst the top health economists in the world, placed 21st on the list of the top 100 health economists, based on a measure of health economics publications and the number of times they have been cited, making her the top-ranked health economist in the UK.